NDC 0944-4351 is a in the category. It is labeled and distributed by .
| Proprietary Name | NDC 0944-4351 |
| Marketing Category | / |
| Marketing Category | BLA |
| Application Number | BLA125266 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2008-03-19 |
| Marketing End Date | 2015-03-31 |
| Marketing Category | BLA |
| Application Number | BLA125266 |
| Product Type | PLASMA DERIVATIVE |
| Marketing Start Date | 2008-03-21 |
| Marketing End Date | 2008-03-21 |
| Marketing Category | BLA |
| Application Number | BLA125266 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-01-11 |
| Marketing End Date | 2015-03-31 |
| Marketing Category | BLA |
| Application Number | BLA125266 |
| Product Type | PLASMA DERIVATIVE |
| Marketing Start Date | 2008-03-19 |
| Marketing End Date | 2015-03-31 |
| Marketing Category | BLA |
| Application Number | BLA125266 |
| Product Type | PLASMA DERIVATIVE |
| Billing Unit | EA |
| Marketing Start Date | 2008-03-19 |
| Marketing End Date | 2015-03-31 |
| Marketing Category | BLA |
| Application Number | BLA125266 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2008-03-08 |
| Marketing End Date | 2009-11-30 |